GSK and Operose Health announce collaborative working project
Quality Improvement Programme to Optimise Shingles National Immunisation Programme Implementation in Underserved and Diverse Populations
The objective of the project is to increase the uptake of the Shingles National Immunisation Programme (NIP) across Operose Health practices, with a specific focus on underserved and diverse populations, via the implementation of a Quality Improvement (QI) Programme.
This project involves a balance of contributions from GSK and Operose Health with the pooling of skills, experience, and resources. The project will run from November 2023 to November 2024.
Read the aims and approach of the project in the Executive Summary by clicking on the below button.